Inventor · disambiguated record
Johannes Voegel
Also filed as: VOEGEL JOHANNES
13 granted patents·15 pending applications·34 citations·filing 1997–2015
88Inventor score
Files withGALDERMA RES & DEV21INST NAT SANTE RECH MED2RETHORE SANDRINE2BOUIX-PETER CLAIRE1UNI MUNSTER1
Top patents by PatentIndex Score
28 records- 0182US7625914B2Compounds that modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Granted Dec 1, 2009·5 cites·38 claims
- 0280US8227514B2Topical application of travoprost for combating hair lossRETHORE SANDRINE·Filed 2010·Granted Jul 24, 2012·7 cites·10 claims
- 0379US6861508B2Transcriptional intermediary factor-2INST NAT SANTE RECH MED·Filed 2001·Granted Mar 1, 2005·6 cites·22 claims
- 0470US7312249B2Vitamin D analoguesGALDERMA RES & DEV·Filed 2005·Granted Dec 25, 2007·1 cites·162 claims
- 0568US6858647B2Retinoid compounds suited for antibacterial applicationsGALDERMA RES & DEV·Filed 2002·Granted Feb 22, 2005·7 cites·55 claims
- 0667US8795705B2Dermatologic compositions comprising pyrrolidone-5-carboxylic acid and at least one entity chosen from citrulline, arginine and asparagine, and uses thereof in the treatment of atopic dermatitisVOEGEL JOHANNES·Filed 2008·Granted Aug 5, 2014·2 cites·17 claims
- 0765US8022079B2Methods of modulating PPAR gamma-type receptorsGALDERMA RES & DEV·Filed 2009·Granted Sep 20, 2011·0 cites·34 claims
- 0865US7968560B2Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compoundsGALDERMA RES & DEV·Filed 2009·Granted Jun 28, 2011·0 cites·31 claims
- 0963US8980948B2Topical application of travoprost for combating hair lossRETHORE SANDRINE·Filed 2012·Granted Mar 17, 2015·0 cites·12 claims
- 1057US8962846B2Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmeticsBOUIX-PETER CLAIRE·Filed 2009·Granted Feb 24, 2015·0 cites·18 claims
- 1156US2011263677A1Gos2 modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1250US2011165168A1Cidea modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1350US2011150773A1Modulators of acetyl-coenzyme a acyltransferase 1 or 2 in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoeaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1449US9610461B2Combination of a MC1R receptor agonist and UVB for the treatment and/or prevention of pigmentation disordersGALDERMA RES & DEV·Filed 2013·Granted Apr 4, 2017·1 cites·15 claims
- 1549US6268173B1Polynucleotide encoding transcriptional intermediary factor-2INST NAT SANTE RECH MED·Filed 1997·Granted Jul 31, 2001·5 cites·38 claims
- 1649US2010168089A1Utilization of tace inhibitors for the treatment of acneGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1748US2010021893A1Modulators of lanosterol synthetase for treating acne or hyperseborrheaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1848US2011229423A1Pacap signaling pathway modulators for treating inflammatory skin diseases having a neurogenic component, notably rosacea, and compositions comprised thereofGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 1948US2009246776A1Modulators of scarb-1 for treating acne or hyperseborrheaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 2047US2010028879A1Modulators of HSD17b7 for treating acne or hyperseborrheaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 2145US2010021892A1Modulators of SC4MOL for treating acne or hyperseborrheaGALDERMA RES & DEV·Filed 2009·Application pending·0 cites
- 2241US2010324111A1Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and aspragine, and use thereof in the tratment of atopic dermatitisGALDERMA RES & DEV·Filed 2010·Application pending·0 cites
- 2341US2010233718A1Non-invasive technique for conducting skin inflammatory disease pharmaco-genomic studies and diagnoses thereofGALDERMA RES & DEV·Filed 2010·Application pending·0 cites
- 2439US9364455B2Combination of a prostaglandin receptor agonist and an MC1R receptor agonist for the treatment and/or prevention of pigmentation disordersGALDERMA RES & DEV·Filed 2012·Granted Jun 14, 2016·0 cites·18 claims
- 2539US2013017969A1Markers and method for the diagnosis of rosaceaUNI MUNSTER·Filed 2010·Application pending·0 cites
- 2639US2006052627A1Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 2738US2006035969A1Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 2834US2015329522A1Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmeticsGALDERMA RES & DEV·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Johannes Voegel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →